Simple and Fast Liquid Chromatography–Mass Spectrometry (LC–MS) Method for the Determination of Omeprazole, 5-hydroxyomeprazole, and Omeprazole Sulphone in Human Plasma

References

• Vanderhoff, B. T.; Tahboub, R. M. Proton Pump Inhibitors: An Update. Am. Fam. Physician 2002, 66 (2), 273–280.
   PubMed Web of Science ®Google Scholar
• Shin, J. M.; Kim, N. Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors. J. Neurogastroenterol. Motil. 2013, 19 (1), 25–35.
   PubMed Web of Science ®Google Scholar
• Lind, T.; Zanten, S. V.; Unge, P.; Spiller, R.; Bayerdörffer, E.; O’Morain, C.; Bardhan, K. D.; Bradette, M.; Chiba, N.; Wrangstadh, M. Eradication of Helicobacter Pylori Using One‐Week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study. Helicobacter 1996, 1 (3), 138–144.
   PubMedGoogle Scholar
• Klinkenberg-Knol, E. C.; Nelis, F.; Dent, J.; Snel, P.; Mitchell, B.; Prichard, P.; Lloyd, D.; Havu, N.; Frame, M. H.; Romàn, J. Long-Term Omeprazole Treatment in Resistant Gastroesophageal Reflux Disease: Efficacy, Safety, and Influence on Gastric Mucosa. Gastroenterology 2000, 118 (4), 661–669.
   PubMed Web of Science ®Google Scholar
• Chiba, K.; Kobayashi, K.; Manabe, K.; Tani, M.; Kamataki, T.; Ishizaki, T. Oxidative Metabolism of Omeprazole in Human Liver Microsomes: Cosegregation with S-Mephenytoin 4′-Hydroxylation. J. Pharmacol. Exper. Therap. 1993, 266 (1), 52–59.
   PubMed Web of Science ®Google Scholar
• Andersson, T.; Miners, J.; Veronese, M.; Tassaneeyakul, W.; Meyer, U.; Birkett, D. Identification of Human Liver Cytochrome P450 Isoforms Mediating Omeprazole Metabolism. Brit. J, Clin. Pharmacol. 1993, 36 (6), 521.
   PubMed Web of Science ®Google Scholar
• Lee, S.-J.; Kim, W.-Y.; Kim, H.; Shon, J.-H.; Lee, S. S.; Shin, J.-G. Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole. Drug Metabol. Disposit. 2009, 37 (11), 2262–2269.
   PubMed Web of Science ®Google Scholar
• Marinac, J. S.; Balian, J. D.; Foxworth, J. W.; Willsie, S. K.; Daus, J. C.; Owen, R.; Flockhart, D. A. Determination of CYP2C19 Phenotype in Black Americans with Omeprazole: Correlation with Genotype. Clin. Pharmacol. Therapeut. 1996, 60 (2), 138–144.
   PubMed Web of Science ®Google Scholar
• Wakasugi, H.; Yano, I.; Ito, T.; Hashida, T.; Futami, T.; Nohara, R.; Sasayama, S.; Inui, K. Effect of Clarithromycin on Renal Excretion of Digoxin: Interaction with P-Glycoprotein. Clin. Pharmacol. Therapeut. 1998, 64 (1), 123–128.
   PubMed Web of Science ®Google Scholar
• Wang, L.; Kitaichi, K.; Hui, C. S.; Takagi, K.; Sakai, M.; Yokogawa, K.; Miyamoto, K.; Hasegawa, T. Reversal of Anticancer Drug Resistance by Macrolide Antibiotics In Vitro and In Vivo. Clin. Experim. Pharmacol. Physiol. 2000, 27 (8), 587–593.
   PubMed Web of Science ®Google Scholar
• Ahmad, L.; Iqbal, Z.; Nazir, S.; Shah, Y.; Khan, A.; Khan, M. I.; Nasir, F.; Khan, A. Optimization and Validation of HPLC-UV Method for Simultaneous Determination of Omeprazole and Its Metabolites in Human Plasma: Effects of Various Experimental Conditions and Parameters. J. Liquid Chromatogr. Rel. Technol. 2011, 34 (15), 1488–1501.
   Web of Science ®Google Scholar
• Kanazawa, H.; Okada, A.; Matsushima, Y.; Yokota, H.; Okubo, S.; Mashige, F.; Nakahara, K. Determination of Omeprazole and Its Metabolites in Human Plasma by Liquid Chromatography–Mass Spectrometry. J. Chromatogr. A 2002, 949 (1), 1–9.
   PubMed Web of Science ®Google Scholar
• Woolf, E.; Matuszewski, B. Simultaneous Determination of Omeprazole and 5′-Hydroxyomeprazole in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry. J. Chromatogr. A 1998, 828 (1), 229–238.
   PubMed Web of Science ®Google Scholar
• Martens-Lobenhoffer, J.; Reiche, I.; Tröger, U.; Mönkemüller, K.; Malfertheiner, P.; Bode-Böger, S. M. Enantioselective Quantification of Omeprazole and Its Main Metabolites in Human Serum by Chiral HPLC–Atmospheric Pressure Photoionization Tandem Mass Spectrometry. J. Chromatogr. B 2007, 857 (2), 301–307.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Wang, Y.; Fawcett, J. P.; Wang, Y.; Gu, J. Determination of Omeprazole in Human Plasma by Liquid Chromatography–Electrospray Quadrupole Linear Ion Trap Mass Spectrometry. J. Pharm. Biomed. Anal. 2005, 39 (3), 631–635.
   PubMed Web of Science ®Google Scholar
• Song, Q.; Naidong, W. Analysis of Omeprazole and 5-OH Omeprazole in Human Plasma Using Hydrophilic Interaction Chromatography with Tandem Mass Spectrometry (HILIC–MS/MS)—Eliminating Evaporation and Reconstitution Steps in 96-Well Liquid/Liquid Extraction. J. Chromatogr. B 2006, 830 (1), 135–142.
   PubMed Web of Science ®Google Scholar
• Hofmann, U.; Schwab, M.; Treiber, G.; Klotz, U. Sensitive Quantification of Omeprazole and Its Metabolites in Human Plasma by Liquid Chromatography–Mass Spectrometry. J. Chromatogr. B 2006, 831 (1), 85–90.
   PubMed Web of Science ®Google Scholar
• Hultman, I.; Stenhoff, H.; Liljeblad, M. Determination of Esomeprazole and Its Two Main Metabolites in Human, Rat and Dog Plasma by Liquid Chromatography with Tandem Mass Spectrometry. J. Chromatogr. B 2007, 848 (2), 317–322.
   PubMed Web of Science ®Google Scholar
• Macek, J.; Klíma, J.; Ptáček, P. Rapid Determination of Omeprazole in Human Plasma by Protein Precipitation and Liquid Chromatography–Tandem Mass Spectrometry. J. Chromatogr. B 2007, 852 (1), 282–287.
   PubMed Web of Science ®Google Scholar
• Kanazawa, H.; Okada, A.; Higaki, M.; Yokota, H.; Mashige, F.; Nakahara, K. Stereospecific Analysis of Omeprazole in Human Plasma as a Probe for CYP2C19 Phenotype. J. Pharm. Biomed. Anal. 2003, 30 (6), 1817–1824.
   PubMed Web of Science ®Google Scholar
• Petsalo, A.; Turpeinen, M.; Pelkonen, O.; Tolonen, A. Analysis of Nine Drugs and Their Cytochrome P450-Specific Probe Metabolites from Urine by Liquid Chromatography–Tandem Mass Spectrometry Utilizing Sub 2 µm Particle Size Column. J. Chromatogr. A 2008, 1215 (1), 107–115.
   PubMed Web of Science ®Google Scholar
• Chung, E.; Ho, E.; Leung, D.; Tang, F.; Yiu, K.; Wan, T. Detection of Anti-Ulcer Drugs and Their Metabolites in Horse Urine by Liquid Chromatography–Mass Spectrometry. Chromatographia 2004, 59 (1), S29–S38.
   Web of Science ®Google Scholar
• Frerichs, V. A.; Zaranek, C.; Haas, C. E. Analysis of Omeprazole, Midazolam and Hydroxy-Metabolites in Plasma Using Liquid Chromatography Coupled to Tandem Mass Spectrometry. J. Chromatogr. B 2005, 824 (1), 71–80.
   PubMed Web of Science ®Google Scholar
• Stenhoff, H.; Blomqvist, Å.; Lagerström, P.-O. Determination of the Enantiomers of Omeprazole in Blood Plasma by Normal-Phase Liquid Chromatography and Detection by Atmospheric Pressure Ionization Tandem Mass Spectrometry. J. Chromatogr. B 1999, 734 (2), 191–201.
   PubMed Web of Science ®Google Scholar
• Yin, O. Q.; Lam, S. S.; Lo, C. M.; Chow, M. S. Rapid Determination of Five Probe Drugs and Their Metabolites in Human Plasma and Urine by Liquid Chromatography/Tandem Mass Spectrometry: Application to Cytochrome P450 Phenotyping Studies. Rapid Comm. Mass Spectr. 2004, 18 (23), 2921–2933.
   PubMed Web of Science ®Google Scholar